NATHBIOGEN

Nath Bio-Genes (India) Share Price

₹192.70 -1.36 (-0.7%)

21 May, 2025 19:53

SIP TrendupStart SIP in NATHBIOGEN

Start SIP

Performance

  • Low
  • ₹190
  • High
  • ₹197
  • 52 Week Low
  • ₹138
  • 52 Week High
  • ₹264
  • Open Price₹194
  • Previous Close₹194
  • Volume61,972

Investment Returns

  • Over 1 Month + 14.57%
  • Over 3 Month + 21.41%
  • Over 6 Month + 9.59%
  • Over 1 Year -1.63%
SIP Lightning

Smart Investing Starts Here Start SIP with Nath Bio-Genes (India) for Steady Growth!

Invest Now

Nath Bio-Genes (India) Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

  • P/E Ratio
  • 9.5
  • PEG Ratio
  • -1.3
  • Market Cap Cr
  • 366
  • P/B Ratio
  • 0.6
  • Average True Range
  • 7.43
  • EPS
  • 20.03
  • Dividend Yield
  • 1
  • MACD Signal
  • 5.16
  • RSI
  • 75.17
  • MFI
  • 92.66

Nath Bio-Genes (India) Financials

Nath Bio-Genes (India) Technicals

EMA & SMA

Current Price
₹192.70
-1.36 (-0.7%)
pointer
  • stock-down_img
  • Bearish Moving Average 0
  • stock-up_img
  • Bullish Moving Average 16
  • 20 Day
  • ₹173.05
  • 50 Day
  • ₹166.22
  • 100 Day
  • ₹169.32
  • 200 Day
  • ₹179.17

Resistance and Support

193.23 Pivot Speed
  • R3 203.47
  • R2 200.23
  • R1 196.47
  • S1 189.47
  • S2 186.23
  • S3 182.47

What's your outlook on Nath Bio-Genes (India)?

You can only vote for once

Ratings

Master Rating

EPS Strenth

Price Strength

Buyer Demand

Group Rank

Nath Bio Genes India has an operating revenue of Rs. 364.91 Cr. on a trailing 12-month basis. An annual revenue growth of 11% is good, Pre-tax margin of 11% is healthy, ROE of 5% is fair but needs improvement. The company has a reasonable debt to equity of 2%, which signals a healthy balance sheet. The stock from a technical standpoint is trading close to its 200DMA and around 20% above its 50DMA. It needs to stay above the 200DMA levels to make any further meaningful move. From an O'Neil Methodology perspective, the stock has an EPS Rank of 56 which is a POOR score indicating inconsistency in earnings, a RS Rating of 72 which is FAIR indicating the recent price performance, Buyer Demand at A+ which is evident from recent demand for the stock, Group Rank of 16 indicates it belongs to a strong industry group of Agricultural Operations and a Master Score of B is close to being the best. Overall, the stock has mediocre technical strength and poor fundamentals, there are superior stocks in the current market environment.

Disclaimer: This stock analysis report is algorithmically generated for informational purposes only and should not be considered as a buy or sell recommendation.

View More

Nath Bio-Genes (India) Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2025-04-29 Audited Results & Final Dividend
2025-01-23 Quarterly Results
2024-10-23 Quarterly Results
2024-08-07 Quarterly Results
2024-05-08 Audited Results & Final Dividend
Date Purpose Remarks
2024-08-09 FINAL Rs.2.00 per share(20%)Final Dividend
View More

Nath Bio-Genes (India) F&O

Nath Bio-Genes (India) Shareholding Pattern

45.6%
3.89%
0.21%
0%
31.94%
18.36%

About Nath Bio-Genes (India)

  • NSE Symbol
  • NATHBIOGEN
  • BSE Symbol
  • 537291
  • Managing Director
  • Mr. Satish Kagliwal
  • ISIN
  • INE448G01010

Similar Stocks to Nath Bio-Genes (India)

Nath Bio-Genes (India) FAQs

Nath Bio-Genes (India) share price is ₹192 As on 21 May, 2025 | 19:39

The Market Cap of Nath Bio-Genes (India) is ₹366.2 Cr As on 21 May, 2025 | 19:39

The P/E ratio of Nath Bio-Genes (India) is 9.5 As on 21 May, 2025 | 19:39

The PB ratio of Nath Bio-Genes (India) is 0.6 As on 21 May, 2025 | 19:39

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23